Immediate Impact
33 standout
Citing Papers
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Works of Nilofer Azad being referenced
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nilofer Azad | 29 | 31 | 16 | 23 | 4 | 57 | |
| Camilla Borges Ferreira Gomes | 21 | 36 | 17 | 13 | 5 | 65 | |
| Tilman L. B. Hölting | 15 | 58 | 19 | 23 | 3 | 81 | |
| Sebastian Vaughan | 15 | 46 | 19 | 10 | 4 | 74 | |
| Annette Kolodzie | 33 | 17 | 21 | 19 | 6 | 55 | |
| Suzanne Allan | 29 | 38 | 16 | 16 | 4 | 62 | |
| Sigrid Kolders | 29 | 18 | 18 | 8 | 3 | 65 | |
| Veerin R. Sirihorachai | 42 | 33 | 15 | 9 | 3 | 64 | |
| Annagrazia Pireddu | 48 | 38 | 27 | 12 | 2 | 75 | |
| Graeme Elliott | 9 | 29 | 7 | 18 | 4 | 56 | |
| Hollie Benson | 25 | 41 | 30 | 25 | 4 | 91 |
All Works
Loading papers...